IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LAGANÀ, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.263
AS - Asia 2.106
EU - Europa 1.639
SA - Sud America 312
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 44
OC - Oceania 4
Totale 7.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.157
SG - Singapore 795
IT - Italia 516
CN - Cina 475
BD - Bangladesh 259
BR - Brasile 252
PL - Polonia 250
FI - Finlandia 200
HK - Hong Kong 188
VN - Vietnam 170
DE - Germania 161
GB - Regno Unito 93
FR - Francia 73
IE - Irlanda 61
TR - Turchia 60
CA - Canada 57
RU - Federazione Russa 57
UA - Ucraina 57
IN - India 42
SE - Svezia 34
NL - Olanda 32
ID - Indonesia 26
MX - Messico 25
AR - Argentina 21
CZ - Repubblica Ceca 18
ZA - Sudafrica 17
BE - Belgio 15
ES - Italia 15
IQ - Iraq 14
JP - Giappone 14
EC - Ecuador 11
AT - Austria 10
CH - Svizzera 10
DZ - Algeria 8
PH - Filippine 8
PK - Pakistan 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 7
CR - Costa Rica 6
PT - Portogallo 6
BG - Bulgaria 5
CO - Colombia 5
HN - Honduras 5
JM - Giamaica 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
LB - Libano 4
RO - Romania 4
AU - Australia 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
CY - Cipro 2
GY - Guiana 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 7.368
Salva come PNG Salva come JPEG
Città #
Singapore 430
Ashburn 341
San Jose 294
Dallas 247
Warsaw 246
Hong Kong 188
Helsinki 148
New York 147
Los Angeles 129
Fairfield 121
Beijing 113
Chandler 92
Council Bluffs 86
The Dalles 79
Chicago 77
Munich 62
Milan 55
Seattle 55
Ho Chi Minh City 54
Wilmington 53
Brescia 52
Columbus 50
Istanbul 46
Lauterbourg 46
Houston 45
Princeton 45
Buffalo 44
Woodbridge 43
Santa Clara 40
Dalmine 39
Jacksonville 39
Cambridge 38
Boardman 37
Turku 35
Redondo Beach 30
Secaucus 30
Shanghai 30
Hanoi 29
Rome 28
Dublin 27
Moscow 26
Jakarta 25
Dong Ket 24
Orem 24
Salt Lake City 24
Naples 23
San Francisco 23
Menlo Park 22
London 21
São Paulo 20
West Jordan 20
Bergamo 19
Des Moines 19
Poplar 18
Nuremberg 17
Ann Arbor 16
Lappeenranta 16
Brno 15
Stockholm 15
Atlanta 14
Boston 14
Brussels 14
Elk Grove Village 14
Rio de Janeiro 14
Toronto 14
Brooklyn 13
Johannesburg 13
Montreal 13
Phoenix 13
Tampa 12
Amsterdam 11
Frankfurt am Main 11
Romola 11
Pune 10
Tokyo 10
Denver 9
Manchester 9
San Diego 9
Turin 9
Biên Hòa 8
Chennai 8
Da Nang 8
Las Vegas 8
Paris 8
Tianjin 8
Bari 7
Brasília 7
Charlotte 7
Dulles 7
Düsseldorf 7
Miami 7
New Delhi 7
Sterling 7
Ankara 6
Curitiba 6
Dearborn 6
Dhaka 6
Guangzhou 6
Livorno 6
Mumbai 6
Totale 4.560
Salva come PNG Salva come JPEG
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 383
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 258
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 230
Immunotherapy failure in adrenocortical cancer: where next? 224
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 200
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 194
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 185
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 183
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 174
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 159
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 155
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 149
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Oncological treatment administration at end of life: a retrospective study 142
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 140
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 134
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 133
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 131
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 131
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 131
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 130
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 128
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 126
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 123
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 121
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 121
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 119
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 119
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 114
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 113
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 113
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 108
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 106
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 103
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 102
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 102
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 102
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 102
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 98
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 95
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 91
Adjuvant denosumab for early breast cancer-Evidence and controversy 90
The Evolving Treatment Landscape of Medullary Thyroid Cancer 87
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 85
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 84
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 80
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 78
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 78
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 68
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 65
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 63
Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis 59
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 58
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 54
Oligometastatic adrenocortical carcinoma: definition and treatment 51
null 51
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 48
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 45
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 43
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study 43
Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis 43
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 40
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 36
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 33
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 32
Primary Adrenal Malignancies 16
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 13
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma 8
Updating ACC preclinical models: characterization of two new patient-derived cell lines 8
Totale 7.495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022255 0 10 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024595 25 19 45 53 55 97 19 32 86 39 15 110
2024/20251.594 51 31 20 266 140 90 114 67 193 90 393 139
2025/20263.760 238 361 376 349 305 247 475 177 265 356 329 282
2026/2027258 159 99 0 0 0 0 0 0 0 0 0 0
Totale 7.495